| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $120K | — | +321.7% |
| SG&A Expense | $366K | — | -11.1% |
| Operating Income | -$486K | — | -10.3% |
| Pre-tax Income | -$486K | — | -10.3% |
| Net Income | -$486K | — | -10.3% |
| EPS (Basic) | -$0.03 | — | +0.0% |
| EPS (Diluted) | -$0.03 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $50K | +0.2% | -96.8% |
| Total Assets | $1.5M | +0.0% | -0.1% |
| Current Liabilities | $5.4M | +9.5% | +46.3% |
| Total Liabilities | $5.4M | +9.5% | +46.3% |
| Stockholders' Equity | -$3.9M | -13.8% | -79.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$374K | — | -28.9% |
| Financing Cash Flow | $372K | — | +15.8% |